{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:09:35Z","timestamp":1789754975428,"version":"4.0.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ejim.2018.04.013","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T02:24:11Z","timestamp":1524104651000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions"],"prefix":"10.1016","volume":"52","author":[{"given":"Gon\u00e7alo J.L.","family":"Cunha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno M.L.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3574-9807","authenticated-orcid":false,"given":"Luiz","family":"Menezes Falc\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2018.04.013_bb0005","author":"Ponikowski","year":"2016"},{"key":"10.1016\/j.ejim.2018.04.013_bb0010","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2018.04.013_bb0015","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cardfail.2011.08.003","article-title":"Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure","volume":"17","author":"Jankowska","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.ejim.2018.04.013_bb0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ejhf.820","article-title":"Iron deficiency and red cell indices in patients with heart failure","volume":"20","author":"Tkaczyszyn","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2018.04.013_bb0025","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/ejhf.837","article-title":"Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: Early in-hospital phase and 30-day follow-up","volume":"19","author":"Van Aelst","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2018.04.013_bb0030","doi-asserted-by":"crossref","first-page":"A779","DOI":"10.1016\/S0735-1097(14)60779-8","article-title":"High prevalence of iron deficiency in patients admitted for acute decompensated heart failure: A french study (CardioFer)","volume":"vol. 63","author":"Cohen-Solal","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0035","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2018.04.013_bb0040","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival","volume":"58","author":"Okonko","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000362888","article-title":"Physiology of iron metabolism","volume":"41","author":"Waldvogel-Abramowski","year":"2014","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.ejim.2018.04.013_bb0050","doi-asserted-by":"crossref","first-page":"G199","DOI":"10.1152\/ajpgi.00412.2005","article-title":"Iron imports. IV. Hepcidin and regulation of body iron metabolism","volume":"290","author":"Ganz","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0055","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1357-2725(99)00070-9","article-title":"The transferrin receptor: role in health and disease","volume":"31","author":"Ponka","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.blre.2017.02.004","article-title":"New insights into iron deficiency and iron deficiency anemia","volume":"31","author":"Camaschella","year":"2017","journal-title":"Blood Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.ejim.2018.04.013_bb0065","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2215\/CJN.01490506","article-title":"Assessing iron status: beyond serum ferritin and transferrin saturation","volume":"1","author":"Wish","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0005-2728(99)00088-2","article-title":"Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation","volume":"1413","author":"Oexle","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ejim.2018.04.013_bb0075","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/ajcn\/45.4.679","article-title":"Recommended dietary intakes (RDI) of iron in humans","volume":"45","author":"Herbert","year":"1987","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ejim.2018.04.013_bb0080","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.numecd.2010.08.006","article-title":"Nutritional intake and oxidative stress in chronic heart failure","volume":"22","author":"Hughes","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.ejim.2018.04.013_bb0085","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/eurheartj\/ehs377","article-title":"Iron status in patients with chronic heart failure","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2018.04.013_bb0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9149(63)90029-8","article-title":"Malabsorption as a complication of congestive heart failure","volume":"11","author":"Berkowitz","year":"1963","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0095","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.gastro.2016.11.023","article-title":"Proton pump inhibitor and histamine-2 receptor antagonist use and iron deficiency","volume":"152","author":"Lam","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2018.04.013_bb0100","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ejhf.84","article-title":"The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences","volume":"16","author":"Klip","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2018.04.013_bb0105","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","article-title":"The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications","volume":"54","author":"Triposkiadis","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.semnephrol.2016.02.001","article-title":"Iron balance and the role of hepcidin in chronic kidney disease","volume":"36","author":"Ganz","year":"2016","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1182\/blood-2017-07-746446","article-title":"Anemia at older age: Etiologies, clinical implications and management","volume":"131","author":"Stauder","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2018.04.013_bb0120","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/eurheartj\/ehs224","article-title":"Iron deficiency and heart failure: Diagnostic dilemmas and therapeutic perspectives","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2018.04.013_bb0125","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2006.08.034","article-title":"Etiology of anemia in patients with advanced heart failure","volume":"48","author":"Nanas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0130","doi-asserted-by":"crossref","first-page":"e004519","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients","volume":"11","author":"Grote Beverborg","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ejim.2018.04.013_bb0135","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijcard.2017.04.110","article-title":"Clinical correlates and prognostic impact of impaired iron storage versus impaired iron transport in an international cohort of 1821 patients with chronic heart failure","volume":"243","author":"Moliner","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0140","doi-asserted-by":"crossref","first-page":"676S","DOI":"10.1093\/jn\/131.2.676S","article-title":"Iron deficiency and reduced work capacity: A critical review of the research to determine a causal relationship","volume":"131","author":"Haas","year":"2001","journal-title":"J Nutr"},{"key":"10.1016\/j.ejim.2018.04.013_bb0145","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.amjcard.2016.02.018","article-title":"Relation of longitudinal changes in quality of life assessments to changes in functional capacity in patients with heart failure with and without anemia","volume":"117","author":"Cooper","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0150","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijcard.2015.11.178","article-title":"The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the studies investigating co-morbidities aggravating heart failure","volume":"205","author":"Ebner","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0155","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","article-title":"Anemia and mortality in heart failure patients a systematic review and meta-analysis","volume":"52","author":"Groenveld","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40256-016-0211-2","article-title":"Iron therapy in patients with heart failure and iron deficiency: review of iron preparations for practitioners","volume":"17","author":"Drozd","year":"2017","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ejim.2018.04.013_bb0165","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/kisup.2012.35","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ejim.2018.04.013_bb0170","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/eurheartj\/ehi388","article-title":"Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure","volume":"26","author":"Opasich","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2018.04.013_bb0175","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.04.013_bb0180","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.04.013_bb0185","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: The IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2018.04.013_bb0190","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ejhf.236","article-title":"Iron therapy for the treatment of iron deficiency in chronic heart failure: Intravenous or oral?","volume":"17","author":"McDonagh","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2018.04.013_bb0195","doi-asserted-by":"crossref","first-page":"991.e1","DOI":"10.1016\/j.amjmed.2017.03.045","article-title":"Iron supplementation, response in iron-deficiency anemia: Analysis of five trials","volume":"130","author":"Okam","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2018.04.013_bb0200","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1525-139x.2000.00104.x","article-title":"The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate","volume":"13","author":"Fishbane","year":"2000","journal-title":"Semin Dial"},{"key":"10.1016\/j.ejim.2018.04.013_bb0205","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jacc.2006.07.015","article-title":"Intravenous iron alone for the treatment of anemia in patients with chronic heart failure","volume":"48","author":"Bolger","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0210","first-page":"236","article-title":"Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency","volume":"21","author":"Usmanov","year":"2008","journal-title":"J Nephrol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0215","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.hlc.2014.12.161","article-title":"Changes in echocardiographic parameters in iron deficiency patients with heart failure and chronic kidney disease treated with intravenous iron","volume":"24","author":"Toblli","year":"2015","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.ejim.2018.04.013_bb0220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: A randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0225","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.ijcard.2013.04.181","article-title":"IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia","volume":"168","author":"Beck-da-Silva","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0230","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.04.013_bb0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/eurheartj\/ehr504","article-title":"The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: A subanalysis of the FAIR-HF study","volume":"34","author":"Comin-Colet","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2018.04.013_bb0240","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ejhf.229","article-title":"The impact of intravenous ferric carboxymaltose on renal function: An analysis of the FAIR-HF study","volume":"17","author":"Ponikowski","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2018.04.013_bb0245","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/eurjhf\/hft099","article-title":"Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: A subanalysis of the FAIR-HF trial","volume":"15","author":"Filippatos","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2018.04.013_bb0250","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency\u2020","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2018.04.013_bb0255","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ejhf.473","article-title":"Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: A meta-analysis of randomized controlled trials","volume":"18","author":"Jankowska","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2018.04.013_bb0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: An individual patient data meta-analysis","volume":"20","author":"Anker","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2018.04.013_bb0265","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2018.04.013_bb0270","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: Systematic review and meta-analysis","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0275","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11255-017-1708-6","article-title":"Iron in kidney and heart failure: From theory to practice","volume":"50","author":"Yerlikaya","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0280","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/j.1523-1755.2004.00648.x","article-title":"Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease","volume":"65","author":"Agarwal","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2018.04.013_bb0285","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/ndt\/gft251","article-title":"Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: The REPAIR-IDA trial","volume":"29","author":"Onken","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2018.04.013_bb0290","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/ki.1996.487","article-title":"A randomized controlled study of iron supplementation in patients treated with erythropoietin","volume":"50","author":"Macdougall","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2018.04.013_bb0295","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000045053","article-title":"Correction of uremic iron deficiency anemia in hemodialyzed patients: A prospective study","volume":"79","author":"Fudin","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.ejim.2018.04.013_bb0300","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0272-6386(95)90151-5","article-title":"Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation","volume":"26","author":"Fishbane","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2018.04.013_bb0305","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000113529","article-title":"Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia","volume":"26","author":"Li","year":"2008","journal-title":"Blood Purif"},{"key":"10.1016\/j.ejim.2018.04.013_bb0310","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: Results of the dialysis patients' response to IV Iron with elevated ferritin (DRIVE) study","volume":"18","author":"Coyne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0315","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1681\/ASN.2007050606","article-title":"Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin","volume":"19","author":"Kapoian","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0320","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2215\/CJN.02840608","article-title":"Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients","volume":"4","author":"Provenzano","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0325","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/ndt\/gfs528","article-title":"Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: A randomized, active-controlled, multi-center study","volume":"28","author":"Charytan","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2018.04.013_bb0330","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/ndt\/gfv096","article-title":"A randomized, open-label trial of iron isomaltoside 1000 (Monofer\u00ae) compared with iron sucrose (Venofer\u00ae) as maintenance therapy in haemodialysis patients","volume":"30","author":"Bhandari","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2018.04.013_bb0335","first-page":"CD007857","article-title":"Parenteral versus oral iron therapy for adults and children with chronic kidney disease","volume":"1","author":"Albaramki","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejim.2018.04.013_bb0340","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.ajkd.2016.04.018","article-title":"Intravenous versus oral Iron supplementation for the treatment of anemia in CKD: An updated systematic review and meta-analysis","volume":"68","author":"Shepshelovich","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2018.04.013_bb0345","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/kisup.2012.34","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ejim.2018.04.013_bb0350","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2215\/CJN.01541005","article-title":"Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: A randomized, controlled trial","volume":"1","author":"Singh","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0355","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/eurjhf\/hfs189","article-title":"Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: The OFICA study","volume":"15","author":"Logeart","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2018.04.013_bb0360","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/ejh.12963","article-title":"Prevalence and prognostic impact of anemia and iron deficiency in patients hospitalized in an internal medicine ward: The PRO-IRON study","volume":"99","author":"Fonseca","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0365","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijcard.2011.02.025","article-title":"Clinical profile and predictors of in-hospital outcome in patients with heart failure: The FADOI \"CONFINE\" Study","volume":"152","author":"Biagi","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0370","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11739-011-0601-z","article-title":"Prevalence and prognostic role of anaemia in patients with acute heart failure and preserved or depressed ventricular function","volume":"8","author":"Tarantini","year":"2013","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.ejim.2018.04.013_bb0375","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.amjcard.2016.03.041","article-title":"Effects of Total dose infusion of iron intravenously in patients with acute heart failure and anemia (hemoglobin\u202f<\u202f13\u202fg\/dl)","volume":"117","author":"Kaminsky","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0380","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ehf2.12250","article-title":"Single-dose intravenous iron in southeast Asian heart failure patients: A pilot randomized placebo-controlled study (PRACTICE-ASIA-HF)","volume":"5","author":"Yeo","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ejim.2018.04.013_bb0385","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","article-title":"The burden of iron deficiency in heart failure: Therapeutic approach","volume":"71","author":"Rocha","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0390","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/phar.1525","article-title":"Effects of an accelerated intravenous iron regimen in hospitalized patients with advanced heart failure and iron deficiency","volume":"35","author":"Reed","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejim.2018.04.013_bb0395","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijcard.2016.07.280","article-title":"Iron deficiency in heart failure: Impact on response to cardiac resynchronization therapy","volume":"222","author":"Bojarczuk","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2018.04.013_bb0400","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.amjcard.2016.09.017","article-title":"Impact of iron deficiency on response to and remodeling after cardiac resynchronization therapy","volume":"119","author":"Martens","year":"2017","journal-title":"Am J Cardiol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362051830150X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362051830150X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T20:12:15Z","timestamp":1538597535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362051830150X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":80,"alternative-id":["S095362051830150X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2018.04.013","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2018.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}